Skip to content

A single-center prospective observational study to investigate the actual situation of acute coronary syndrome and myocardial infarction with non-obstructive arteries.

A single-center prospective observational study to investigate the actual situation of acute coronary syndrome and myocardial infarction with non-obstructive arteries. - A single-center prospective observational study to investigate the actual situation of acute coronary syndrome and myocardial infarction with non-obstructive arteries.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053548
Enrollment
500
Registered
2024-02-06
Start date
2024-01-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome and myocardial infarction with non-obstructive arteries

Interventions

None listed

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who understood the contents of the written informed consent provided by the research director or co-investigator and signed the consent form in their own handwriting or by their representative. Patients diagnosed with acute myocardial infarction and MINOCA who underwent emergency coronary angiography and/or percutaneous coronary intervention due to clinical necessity.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Diseases of patients who underwent emergency cardiac catheterization and/or percutaneous coronary intervention for acute coronary syndrome or MINOCA (acute coronary syndrome [STEMI, NSTEMI, UAP], MINOCA [plaque rupture/erosion, coronary spasm, coronary artery Dissection, acute aortic dissection, microangiopathy, coronary thrombosis [due to thrombotic predisposition], coronary embolism, sympathomimetic drugs [cocaine, methamphetamine], myocarditis, Takotsubo cardiomyopathy, other cardiomyopathy, cardiac trauma, excessive exercise, Tachyarrhythmia, drug-induced myocardial injury [chemotherapy], disruption of oxygen supply and demand balance [type-2 myocardial infarction], cerebral infarction, pulmonary thromboembolism, sepsis, acute respiratory distress syndrome, end-stage renal failure, cause unknown]) ratio of

Countries

Japan

Contacts

Public ContactJumpei Takeda

Wakayama Medical University Department of Cardiovascular Medicine

jtakeda@wakayama-med.ac.jp073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026